Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001680581-17-000002
Filing Date
2017-07-25
Accepted
2017-07-25 09:27:39
Documents
1
Effectiveness Date
2017-07-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8252
  Complete submission text file 0001680581-17-000002.txt   9353
Mailing Address ONE KENDALL SQUARE BUILDING 700, SUITE B7102 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 700, SUITE B7102 CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-267612 | Film No.: 17979453